Gender-Responsive Drug Use Treatment for Juvenile Justice Girls

描述（由申请人提供）：与没有犯罪的女性和男性犯罪对象相比，犯罪女孩患物质使用障碍、精神症状和负面健康后果（如艾滋病毒/艾滋病或其他性传播感染）的风险要大得多。研究表明，女孩在吸毒、最初涉入法律和同时出现的负面健康后果方面可能有不同的发展途径，这支持了为少年司法女孩测试针对性别的治疗方法的重要性。虽然最近越来越强调少年司法中针对性别的方案，但缺乏有经验支持的针对性别的干预措施，以改善少年司法女孩的健康、心理健康和/或法律结果。因此，本II期治疗试验的目的是测试在200名法院参与的非监禁（CINI）女孩中预先存在的、广泛传播的性别敏感药物使用治疗（VOICES）的疗效。我们试图测试VOICES对CINI女孩药物和酒精使用、艾滋病毒/性传播感染风险、精神症状和再犯的影响，并探索结果的调节因子和调节因子。将从罗德岛家庭法院招募年龄在12-18岁的CINI女孩（N= 6名青少年进行第一阶段干预；N=200名进行第二阶段随机对照研究），随机分配到voice（主动）干预组（N= 100）或标准护理组（对照）条件组（N= 100）。在第一阶段（一年级的前六个月），将招募6名青少年完成一次干预预演和研究评估，以便在RCT阶段之前测试RCT干预和评估程序。在第二阶段（一年级后半段至四年级），将招募200名青少年并在基线时随机分配，然后在治疗中期、治疗结束时重新评估，以及干预后3、6、9和12个月的随访。青少年吸毒和性传播感染的生物标本也将在每3个月的评估中收集。疗效试验结果可用于立即改变目前广泛实施的方案，从而直接影响针对少年司法女童的循证性别敏感药物使用干预措施领域。

DESCRIPTION (provided by applicant): Compared to both non-offending females and male offending counterparts, offending girls are at significantly greater risk for the development of substance use disorders, psychiatric symptoms and negative health outcomes, such as HIV/AIDS or other sexually transmitted infections (STIs). Research suggests that girls may have different developmental pathways to drug use, initial legal involvement and co-occurring negative health outcomes that support the importance of testing gender-specific treatments for juvenile justice girls. Although there is recent increased emphasis on gender-specific programming in juvenile justice, empirically supported gender specific interventions to improve health, mental health and/or legal outcomes among juvenile justice girls are lacking. The objective of this Stage II treatment trial is therefore to test the efficacy of a pre-existing, widly disseminated gender-responsive drug use treatment (VOICES) among 200 court-involved, non- incarcerated (CINI) girls. We seek to test the effect of VOICES on CINI girls' drug and alcohol use, HIV/STI risk, psychiatric symptoms and recidivism as well as explore moderators and mediators of outcomes. CINI girls, ages 12-18 (N= 6 juveniles for Phase I Intervention Run-Through; N=200 for Phase II RCT study) will be recruited from the Rhode Island Family Court and randomized to either the VOICES (active) intervention (n=100) or a Standard of Care (control) condition (n=100). In Phase I (first six months of Year 1), 6 juveniles will be recruitedto complete the Intervention Run-Through and research assessment once to allow testing of RCT intervention and assessment procedures prior to the RCT phase. In Phase II (last half of Year 1 through Year 4), 200 juveniles will be recruited and randomized at baseline and then re-assessed at mid-treatment, end of treatment, and 3, 6, 9 and 12 month post-intervention follow-ups. Biological specimens for juvenile drug use and sexually transmitted infections (STIs) will also be collected at each 3-month assessment. Efficacy trial results can be used to make immediate changes to current widespread program delivery resulting in direct impact on the field of evidence-based gender-responsive substance use interventions for juvenile justice girls.